Key points are not available for this paper at this time.
Design
Editorial
Answers are grounded in this paper and cite their sources.
This symposium summary highlights the translational potential of research on brain-heart interactions and autonomic function over the past 50 years.
The heart, although endowed with intrinsic automaticity, is normally subject to a host of influences arising from almost all the other organs of the body. These signals shape the activity of the heart, optimizing its functional efficiency in order to meet the changing needs of the organism on a minute-to-minute basis. John Coote, currently Emeritus Professor of Physiology at the University of Birmingham, UK has devoted a lifetime's work to the study of nervous control of the heart and other organs. The collection of papers in this issue of Experimental Physiology describes many of the facets of the interaction of the heart with the nervous system, based on presentations made on 21 July 2013 at the Special Symposium in his honour entitled Brain–Heart Interactions in Health and Disease, a symposium in honour of Professor John H. Coote at IUPS 2013, the XXXVII International Congress of Physiological Sciences, held in Birmingham, UK. To set the scene, a fascinating historical review by White (2014) summarizes key events in the discovery of reflex pathways capable of signalling to the CNS information about metabolic conditions and mechanical activity in the exercising muscle. As a consequence of this work, the concepts evolved of the ‘muscle metaboreflex’ elicited by afferents discharging in response to metabolites accumulated within the muscle interstitium and the ‘muscle mechanoreflex’ evoked by those responding primarily to mechanical stimuli. The complexity of sympathetic–parasympathetic interaction in influencing the activity of the heart is highlighted by Fisher (2014), who demonstrated how inhibition of cardiac parasympathetic activity evoked by feedback from mechanically sensitive muscle afferents permits increases in heart rate at the onset of exercise, whereas sympathetically mediated tachycardia evoked by metabolically sensitive afferents subsequently maintains the activity of the heart. The clinical importance of this work is evidenced by the realization that abnormal afferent feedback may explain effort intolerance in humans. It has long been known that the heart plays an important role in regulating blood volume. In reviewing current knowledge, Hainsworth (2014) shows that feedback from low-pressure atrial receptors and coronary and pulmonary arterial baroreceptors is important in regulating blood volume by influencing activity not only via the renal nerves but also by secretion of antidiuretic hormone. In contrast, receptors in the ventricle, which produce powerful depressor effects, appear to be activated principally in pathophysiogical conditions. Interestingly, the sympathetic innervation of the kidney is now a therapeutic target for the regulation of blood pressure. Johns (2014) shows how bilateral renal denervation of resistant hypertensive patients can cause a marked and long-lasting reduction in blood pressure. Although the underlying mechanism is far from clear, such is the success of the procedure that the approach is being applied in other patient groups with diabetes, obesity and renal failure, with the hope that there may be a sustained reduction not only in blood pressure but also in aspects of the metabolic syndrome. The vagal influence on the heart has long been recognized to be protective against development of arrhythmias. Classically, the ventricle was thought to receive very little vagal innervation, but Ng (2014) shows compelling data demonstrating not only a significant vagal innervation of the ventricle but also that nitric oxide, rather than cholinergic influences, mediates the antifibrillatory effect of cervical vagal stimulation. Moving to the realms of central nervous control of the heart and pathophysiological states, Pyner (2014) describes anatomical connections of the paraventricular nucleus and considers how this circuitry might be implicated in heart failure. Examples of the translational potential of studies on brain–heart interactions carried out in animal models are highlighted in the papers by Lovick (2014) and Cechetto (2014). Physiologists have long used deep brain stimulation (DBS) as a tool for investigating neural control of autonomic function. Following discoveries of the ability of DBS at midbrain sites to modulate cardiovascular function via long-term lowering of blood pressure and baroreflex sensitivity, the potential to exploit DBS in other sectors of the clinical autonomic arena is being investigated. In collaboration with John Coote and a neurosurgical team form Oxford, UK, Lovick describes how, as has been shown in animal models, midbrain DBS in humans can enhance bladder storage capacity in humans too. These studies highlight the potential of developing DBS as a therapeutic option for controlling some forms of urinary incontinence. Functional magnetic resonance imaging is another tool that is revolutionizing our understanding of the central control of autonomic physiology in humans. Such studies offer the added advantage of being to distinguish voluntary from purely reflex autonomic components. In his elegant studies, Cechetto (2014) has been able to distinguish between active and passive cardiovascular afferent activation using a combination of active command to elicit cardiovascular responses and a passive approach using drug injections. The role of the insular and infralimbic cortices is central to these effects. However, there appears to be considerable individual variation in the pathways in the cortex, which may be linked to past experience, including childhood trauma. This could become important in the future in directing the development of personalized medicine. The contributors to this symposium highlighted how the field of brain–heart interactions has progressed. The early work carried out in animal models is not only being replicated in humans, but also expanded and extended. The translational potential of the knowledge base accumulated over the past 50 years is exciting and heralds the beginning of a new era in the development of new forms treatment of disordered autonomic function. Readers are invited to give their opinion on the articles in this Symposium set. To submit a comment, go to: http://ep.physoc.org/letters/submit/expphysiol;99/2/287.
No takes yet. Share an insight, caveat, or question.
T.A. Lovick (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: